SciELO - Scientific Electronic Library Online

 
vol.56 issue3Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F expertsCerebral venous thrombosis: Study of fifteen cases and review of literature author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista da Associação Médica Brasileira

Print version ISSN 0104-4230

Abstract

CARVALHO, Leda Viegas de et al. Molecular characterization of breast cancer in young Brazilian women. Rev. Assoc. Med. Bras. [online]. 2010, vol.56, n.3, pp. 278-287. ISSN 0104-4230.  http://dx.doi.org/10.1590/S0104-42302010000300010.

OBJECTIVE: To evaluate the distribution of molecular subtypes of breast tumors diagnosed in young Brazilian women and to analyze the frequency of loss of heterozygocity (LOH) in BRCA1 among different molecular subtypes of early-onset breast cancer. METHODS: Samples from 72 cases of invasive breast carcinoma diagnosed in women aged between 19 and 40 years were evaluated using an immunohistochemical panel of biomarkers. Three intragenic BRCA1 locus microsatellites, D17S1322, D17S1323, and D17S855, were PCR amplified from matched normal (lymphocyte) and tumor DNAs for (LOH) analysis. RESULTS: We found 13 cases (18%) that had an immunohistochemical profile consistent with being basal-like. Forty cases (55%) were luminal A type; 11% (8 cases) were luminal B type, 13% (9 cases) were HER2-overexpressing tumors and two cases were ER-/HER2- carcinomas lacking basal marker expression. Four of the 16 informative cases at D17S1322, one of the four informative cases at D17S855, and none of the five informative cases at D17S1323 displayed LOH (four basal-like and one Luminal A). Microsatellite instability (MSI) at D17S855 and D17S1322 was found in two cases (one a basal-like and one Luminal A). CONCLUSION: In our study, basal-like tumor was the second most frequent molecular type among young Brazilian women and was only observed in women diagnosed under the age of 35 years. There was no significant difference of LOH at BRCA1 locus rates between basal-like breast tumors and not-basal-like breast tumors (p=0.62). LOH in BRCA1 and MSI in these breast cancers were not frequent but may indicate a small group of breast cancers with a specific molecular makeup.

Keywords : Breast neoplasms; Immunohistochemistry; Genes, BRCA1; Loss of heterozygosity; Microsatellite instability.

        · abstract in Portuguese     · text in English     · pdf in English